EY Health Sciences & Wellness podcast series
News:Business News
There are 2,600 cell and gene therapy clinical trials taking place this year. In the US alone, this could translate up to 20 new therapy approvals in 2022, which presents a clear opportunity to make more life-saving therapies available to a greater number of individuals. In this podcast, Adlai Goldberg, Global Digital, Social and Commercial Innovation Life Sciences Leader for EY, talks to Tamie Joeckel – ICON’s Cell and Gene Therapy Global Business Lead, as they discuss what makes an increase in the volume of trials and an acceleration of the clinical trial process significant.
How the path to a sustainable health system unlocks value
How global events are shaping the pharmaceutical supply chain
How life sciences companies are measuring their ESG impact
How unlocking the power of data can fuel better health outcomes
How women are shaping the life sciences industry
How data can help redesign the health experience
How digital solutions will help close the health equity gap
The Age of Health Experience
Create your
podcast in
minutes
It is Free
Pharmacy Podcast Network
Sarah Westall - Business Game Changers
Startitup podcasty
Wall Street Breakfast
Bloomberg Surveillance